Judge OKs Aphton Sale Of Cancer Drug
U.S. Judge Christopher Sontchi approved the $750,000 cash sale of the vaccine candidate, Insegia, in the U.S. Bankruptcy Court for the District of Delaware on Friday after the price increased 50% at auction.
Aphton, which develops cancer immunotherapies, slipped into Chapter 11 in May after a number of business deals fell apart.
New York-based hedge fund NGN Capital stood...
To view the full article, register now.